Tocilizumab in severe COVID-19
Arch Med Sci
.
2020 Jul 16;16(6):1457-1458.
doi: 10.5114/aoms.2020.97411.
eCollection 2020.
Authors
Nicola Lucio Liberato
1
,
Andrea De Monte
2
,
Giuseppe Caravella
3
Affiliations
1
Department of Medicine, ASST Melegnano e della Martesana, Vizzolo Predabissi (MI), Italy.
2
Department of Oncology, ASST Melegnano e della Martesana, Vizzolo Predabissi (MI), Italy.
3
Department of Pharmacy, ASST Melegnano e della Martesana, Vizzolo Predabissi (MI), Italy.
PMID:
33224347
PMCID:
PMC7667418
DOI:
10.5114/aoms.2020.97411
No abstract available